Chronic obstructive pulmonary disease (COPD) as a common, preventable and treatable
chronic respiratory disease in clinic, gets continuous deterioration and we can't take effective …

Systemic inflammation is established as part of late-stage severe lung disease, but
molecular, functional, and phenotypic changes in peripheral immune cells in early disease …

Tobacco smoking doubles the risk of active tuberculosis (TB) and accounts for up to 20% of
all active TB cases globally. How smoking promotes lung microenvironments permissive to …

Background Chronic obstructive pulmonary disease (COPD) remains a leading cause of
morbidity and mortality worldwide, characterized by persistent respiratory symptoms and …

Smoking is a leading risk factor of chronic obstructive pulmonary disease (COPD), that is
characterized by chronic lung inflammation, tissue remodeling and emphysema. Although …

Introduction People living with HIV (PLHIV) are characterized by functional reprogramming
of innate immune cells even after long-term antiretroviral therapy (ART). In order to assess …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and
health care use worldwide with heterogeneous pathogenesis. Mitochondria, the …

Simple Summary The interaction between the immune system, chronic obstructive
pulmonary disease (COPD), and non-small cell lung cancer (NSCLC) is complex and …

The current studies have shown that the occurrence and development of chronic obstructive
pulmonary disease (COPD) are closely related to the changes in gut health and its …

Interstitial lung disease (ILD) is a serious complication of connective tissue diseases (CTDs).
The heterogeneity of ILDs reflects differences in pathogenesis among diseases. This study …